Publications by authors named "G I Drosos"
The use of minimum common data set in the development of the Greek Fragility Hip Fracture Registry in the Greek health care setting: the first year of its pilot implementation.
Efthymios Iliopoulos Theodoros Tosounidis Reichan Molla Moustafa Fotios Tilkidis Ioannis Daskalakis Georgios Drosos
Arch Osteoporos
September 2024
Unlabelled: The first Fragility Hip Fracture Registry has been established in Greece. The in-hospital length of stay was 10.8 days and was significantly influenced by the delayed surgical fixation.
View Article and Find Full Text PDFArticle Synopsis
- Imaging techniques, particularly ultrasound (US), have greatly enhanced physicians' ability to diagnose and differentiate conditions in pediatric orthopedic patients.
- This review highlights US applications in trauma (like fractures), developmental disorders (e.g., hip dysplasia), soft tissue issues (such as cysts and tumors), and various musculoskeletal conditions.
- US is an effective, low-cost, and non-invasive tool that, despite requiring expertise, provides safer procedures and is essential for orthopedic surgeons.
The management of complex and severe lower-extremity injuries is challenging for the orthopedic surgeon. When the primary or secondary closure of the defect is not feasible, complex procedures with graft (split-thickness or full-thickness) or flap (pedicled or free) are required. These procedures are performed by specialized plastic surgeons and are at high risk for adverse effects, even high morbidity among both the donor and acceptor sites.
View Article and Find Full Text PDFArticle Synopsis
- Circulating cell-free DNA (ccfDNA) of mitochondrial origin (ccf-mtDNA) is a small part of the total ccfDNA in bodily fluids, with abnormal levels linked to various diseases.
- A new standardized dual-qPCR assay effectively measures nuclear and mitochondrial ccfDNA, revealing that high ccf-mtDNA levels are significant in Breast Cancer and Type 2 Diabetes, but not in Osteoarthritis.
- Machine learning was applied to create biosignatures for diagnosing and predicting outcomes in these diseases, highlighting their potential in improving clinical management.